The federal 340B Drug Pricing Program was created to assist safety-net providers “to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.” Since then, this program has become critically important to Community Health Centers. It allows health centers to purchase outpatient medications at significantly reduced costs, enabling them to provide affordable discounted or free medications to uninsured and underinsured patients. By law and statute, health centers are required to invest every penny of 340B savings into activities that expand access for their patients. The 340B program generates savings that are reinvested in the health center to meet the unique needs of their communities like dental care, behavioral health, specialty care, translation services, food banks, housing support, and co-pay assistance programs.
NACHC monitors policy and regulatory issues related to 340B closely. Visit our 340B Policy page.
- 340B Manufacturer Restriction on Contract Pharmacies Chart Sep 29, 2023 PDFs/Documents
- 340B Referral Mgmt_February 2023 Mar 23, 2023 PDFs/Documents
- NACHC Statement Regarding HHS Dismissal of ADR Resolution on 340B Sep 17, 2022 Policy Statement
- Diabetes Drug Alternatives Given 340B Pharmaceutical Restrictions Aug 23, 2022 PDFs/Documents
- Health Centers and 340B: Funding Health Equity Aug 02, 2022 Infographic
- Infographic: Health Centers and 340B --Funding Health Equity Aug 02, 2022 Infographic
- Primer on Health Center Pharmacy Operations Jul 26, 2022 PDFs/Documents
- 340B: A Critical Program for Health Centers Jun 13, 2022 PDFs/Documents
- Infographic: 340B Improves Health Access for Patients Jun 02, 2022 Infographic
- Pharmacy Office Hours Mar 21, 2023 Webinar